BioRestorative Therapies Has Been Granted A License By The New York State Department Of Health To Operate As A Tissue Bank; The License Enables BioRestorative To Process Mesenchymal Stem Cells Obtained From Autologous Donors
Portfolio Pulse from Benzinga Newsdesk
BioRestorative Therapies has received a license from the New York State Department of Health to operate as a tissue bank. This license allows the company to process mesenchymal stem cells obtained from autologous donors.
July 21, 2023 | 11:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioRestorative Therapies' new license to operate as a tissue bank could potentially expand its services and increase its revenue.
The license granted to BioRestorative Therapies by the New York State Department of Health allows the company to process mesenchymal stem cells from autologous donors. This could potentially expand the company's services and increase its revenue, which could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100